199 related articles for article (PubMed ID: 19708543)
1. [Use of PET/CT examination in head and neck cancer radiotherapy planning].
Kolárová I; Vanásek J; Odrázka K; Petruzelka L; Dolezel M; Nechvíl J
Klin Onkol; 2009; 22(3):98-103. PubMed ID: 19708543
[TBL] [Abstract][Full Text] [Related]
2. PET/CT significance for planning radiotherapy of head and neck cancer.
Kolarova I; Vanasek J; Kandrnal V; Odrazka K; Dusek L; Chrobok V; Belohlavek O; Dolezel M; Petruzelka L; Michalek R; Jarkovsky J
Neoplasma; 2012; 59(5):536-40. PubMed ID: 22668019
[TBL] [Abstract][Full Text] [Related]
3. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
6. [PET/CT based radiotherapy treatment planning in head and neck cancers].
Sinkó D; Klinkó T; Weisz C; Nemeskéri C; Fekésházy A; Tóth V; Tóth Z; Mayer A
Orv Hetil; 2009 Jul; 150(30):1403-6. PubMed ID: 19592335
[TBL] [Abstract][Full Text] [Related]
7. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy.
Solberg TD; Agazaryan N; Goss BW; Dahlbom M; Lee SP
J Neurosurg; 2004 Nov; 101 Suppl 3():381-9. PubMed ID: 15537193
[TBL] [Abstract][Full Text] [Related]
8. Role of PET/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy.
Arslan S; Abakay CD; Sen F; Altay A; Akpinar T; Ekinci AS; Esbah O; Uslu N; Kekilli KE; Ozkan L
Asian Pac J Cancer Prev; 2014; 15(24):10899-903. PubMed ID: 25605198
[TBL] [Abstract][Full Text] [Related]
9. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
[TBL] [Abstract][Full Text] [Related]
10. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
[TBL] [Abstract][Full Text] [Related]
11. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
12. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas.
Nishioka T; Shiga T; Shirato H; Tsukamoto E; Tsuchiya K; Kato T; Ohmori K; Yamazaki A; Aoyama H; Hashimoto S; Chang TC; Miyasaka K
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1051-7. PubMed ID: 12095574
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract][Full Text] [Related]
14. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
Head Neck; 2005 Jun; 27(6):494-502. PubMed ID: 15772951
[TBL] [Abstract][Full Text] [Related]
15. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
16. Specific recommendations for accurate and direct use of PET-CT in PET guided radiotherapy for head and neck sites.
Thomas CM; Pike LC; Hartill CE; Baker S; Woods E; Convery DJ; Greener AG
Med Phys; 2014 Apr; 41(4):041710. PubMed ID: 24694130
[TBL] [Abstract][Full Text] [Related]
17. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.
Ciernik IF; Dizendorf E; Baumert BG; Reiner B; Burger C; Davis JB; Lütolf UM; Steinert HC; Von Schulthess GK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):853-63. PubMed ID: 14529793
[TBL] [Abstract][Full Text] [Related]
18. A new role of PET/CT for target delineation for radiotherapy treatment planning for head and neck carcinomas.
Zygogianni A; Kyrgias G; Kouvaris J; Pistevou-Gompaki K; Kouloulias V
Hell J Nucl Med; 2012; 15(2):139-43. PubMed ID: 22833861
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
Newbold KL; Partridge M; Cook G; Sharma B; Rhys-Evans P; Harrington KJ; Nutting CM
Acta Oncol; 2008; 47(7):1229-36. PubMed ID: 18661420
[TBL] [Abstract][Full Text] [Related]
20. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
